Pharmaceutical company Teva has agreed in principle to pay $4.25 billion after reaching a nationwide settlement with multiple states and local governments over its alleged role in the U.S. opioid crisis.
The Israeli-based pharma giant on July 26 announced the agreement, which is set to end thousands of lawsuits filed against the company.
